WASHINGTON – On the occasion of the one-year anniversary of the U.S.-Mexico-Canada Agreement coming into force, the Association for Accessible Medicines (AAM) releases the following statement:

Dan Leonard

“One year ago today, the U.S.-Mexico-Canada Agreement set the standard for a modern trade agreement. By balancing support for pharmaceutical innovation with generic and biosimilar competition, USMCA is a win for companies, health systems, patients and taxpayers, said AAM President and CEO Dan Leonard.

The broad bipartisan support this agreement received in Congress demonstrates the importance of access to medicines as a key component of U.S. trade policy. The Association of Accessible Medicines stands with the Biden Administration, Congress and our trading partners in working to ensure that all future trade agreements reflect this critical balance.